AP NEWS
Press release content from PR Newswire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from PR Newswire
Press release content from PR Newswire. The AP news staff was not involved in its creation.

Engine Capital Issues Open Letter to Board of PDL BioPharma

October 23, 2019 GMT

NEW YORK, Oct. 23, 2019 /PRNewswire/ -- Engine Capital LP (together with its affiliates, “Engine”), a significant shareholder of PDL BioPharma, Inc. (the “Company”) (NASDAQ:PDLI), with ownership of approximately 5.3% of the Company’s outstanding shares, today issued an open letter to the Company’s Board of Directors (the “Board”) encouraging the Company to immediately cease its investment activities and commence a review of strategic alternatives, including a possible sale or liquidation of the Company.

The full text of Engine’s letter to the Board can be viewed at the following link:

www.enginecap.com/pdli

About Engine Capital

Engine Capital is a value-oriented special situations fund that invests both actively and passively in companies undergoing change.

Investor contact:
Engine Capital, L.P.
Arnaud Ajdler
(212) 321-0048
aajdler@enginecap.com

View original content: http://www.prnewswire.com/news-releases/engine-capital-issues-open-letter-to-board-of-pdl-biopharma-300943564.html

SOURCE Engine Capital, L.P.